semaglutide advisory committee Nutritional priorities to support GLP-1 therapy for obesity: a joint from the American College of Lifestyle Medicine, the American Society for Nutrition, the Obesity Medicine Association, and The Obesity Society - Semaglutide Gets FDA Advisory Committee
Description
In this episode, Steve Kraus sits down with Evan Richardson, founder and CEO of Form Health, to discuss GLP-1s and the virtual medical weight loss car

Semaglutide reduces appetite, making protein intake harder to achieveyet preserving lean muscle requires adequate daily protein

Patent expiry on blockbuster drugs opens door to manufacturing boom

Access to the WeightCare One app to track progress and chat with nutritionists and trainers
Pricing $149-299/mo, Semaglutide, tirzepatide, insurance accepted
